Your session is about to expire
← Back to Search
Oxytocin for Alcoholism
Study Summary
This trial is testing whether oxytocin, a hormone that has been shown to reduce substance use behaviors and improve the neurobiological foundations of addiction, can improve outcomes in Alcohol Behavioral Couples Therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently experiencing severe symptoms of alcohol withdrawal.I do not have any conditions or implants that prevent me from undergoing an MRI.I have been on a stable dose of my mental health medication for at least 4 weeks.You have had at least one episode of heavy drinking in the past 60 days, as reported by the study.I have been on a stable dose of my mental health medication for at least 4 weeks.I can understand and agree to the study's requirements.You and your partner both have a diagnosis of alcohol use disorder (AUD) based on specific criteria from a mental health guide called DSM-5.I have been in a committed relationship for at least 6 months.I am between 18 and 75 years old.I have experienced severe violence from a partner in the last 6 months.I can understand and agree to the study's requirements.I have a history of seizures or a seizure disorder.I am between 18 and 75 years old.I do not have a history or current diagnosis of severe mental health disorders like psychosis or bipolar disorder, nor do I have thoughts of harming myself or others.I have been in a committed relationship for at least 6 months.
- Group 1: Placebo
- Group 2: Oxytocin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What indications typically warrant Oxytocin treatment?
"Oxytocin is a commonly employed treatment for issues like hemorrhage, labour augmentation, uterine contraction induction, and the strengthening of labor."
Could individuals aged fifty and above participate in this trial?
"This experiment is open to those 18-75 years old, with 29 trials for minors and 234 focused on seniors."
Is recruitment currently occurring for this clinical trial?
"Affirmative. According to information available on clinicaltrials.gov, this research study is in the midst of recruiting participants at one location with an intended sample size of 200 individuals - it was initial posted on May 16th 2019 and most recently updated December 16th 2021."
Is Oxytocin sanctioned for therapeutic use by the FDA?
"Despite the lack of evidence in favor of Oxytocin's efficacy, prior clinical data suggests that it can be deemed relatively safe and so is given a score of two."
What is the current enrollment tally for this research endeavor?
"Affirmative, clinicaltrials.gov lists this particular trial as open for recruitment. It was initially made available to the public on May 16th 2019 and last updated December 16th 2021. A total of 200 participants are needed at one location."
What type of individuals have the greatest potential to benefit from participating in this clinical study?
"This clinical trial is looking for 200 consenting adults between 18 and 75 years old who suffer from alcohol addiction. Eligibility criteria necessitates that the participant is married, cohabiting for at least six months or in a dedicated relationship of one year duration; male or female, any race/ethnicity; experienced hazardous drinking episode within last two months; meets DSM-5 diagnostic conditions of recent (last 6 month) alcohol use disorder; can have concurrent substance abuse provided that alcoholic beverages are their primary choice of intoxicant and taking psychotropic medications with consistent dose over 4 weeks prior to study onset as fluctuating doses may compromise outcomes."
Share this study with friends
Copy Link
Messenger